Oncology Information System Market Size and Share Analysis - Growth Trends and Forecasts (2025-2032)

Market Size and Trends

The Oncology Information System is estimated to be valued at USD 1.8 billion in 2025 and is expected to reach USD 3.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 11.2% from 2024 to 2031. This significant growth reflects increasing adoption of advanced informatics solutions in oncology care, driven by the need for integrated patient data management, improved treatment planning, and enhanced clinical outcomes across healthcare providers globally.

A key market trend is the rising integration of artificial intelligence (AI) and machine learning (ML) within oncology information systems, enabling predictive analytics and personalized treatment protocols. Furthermore, the shift toward value-based care is encouraging healthcare institutions to deploy systems that optimize workflow efficiency and patient management. Increasing investment in cancer research and digital health infrastructure, along with regulatory support for health IT, continues to propel innovation and adoption in this rapidly evolving market.

Segmental Analysis:

By System Type: Advancements in Precision and Personalization Driving Treatment Planning Systems

In terms of By System Type, Treatment Planning Systems contribute the highest share of the Oncology Information System market owing to their critical role in delivering personalized cancer care. These systems support oncologists and radiation therapists in developing customized treatment regimens by accurately mapping tumors and optimizing radiation doses, which significantly improves patient outcomes. The increasing adoption of advanced imaging modalities and integration of artificial intelligence algorithms within these systems has enhanced the precision of treatment plans, making them indispensable in modern oncology practice. Furthermore, the rising prevalence of cancer and the growing emphasis on minimally invasive and targeted therapies have escalated demand for sophisticated treatment planning solutions. These systems also facilitate multidisciplinary collaboration by enabling seamless data sharing across care teams, which is essential for complex oncology cases. Consequently, healthcare providers prioritize investment in treatment planning platforms to enhance therapeutic accuracy, reduce side effects, and improve overall survival rates, solidifying their dominance in the market.

By Component: Software Solutions Leading the Drive Toward Integrated Oncology Care

By Component, Software segments represent the highest market contribution within Oncology Information Systems due to their pivotal role in enabling comprehensive, end-to-end cancer treatment management. Oncology software encompasses a wide array of applications, including electronic health records, treatment planning tools, chemotherapy management modules, and clinical decision support systems. The rising complexity of cancer treatment pathways and the need for real-time data accessibility have necessitated the adoption of integrated software platforms that streamline workflow, ensure data accuracy, and facilitate regulatory compliance. Additionally, software solutions offer scalability and flexibility through cloud-based deployment, enabling healthcare institutions of varying sizes to benefit from cutting-edge oncology management tools. Enhanced interoperability with diagnostic devices and other healthcare IT systems further drives software demand by fostering a holistic approach to patient care. Moreover, ongoing software innovation focused on predictive analytics, treatment outcome tracking, and patient engagement continues to propel growth, allowing clinicians to deliver personalized therapies with greater efficiency and insight.

By End-User: Hospitals and Cancer Centers as the Central Hub for Advanced Oncology Solutions

By End-User, Hospitals and Cancer Centers account for the largest share of the Oncology Information System market because they serve as principal providers of comprehensive cancer care, combining diagnostic, therapeutic, and research capabilities under one roof. These institutions require robust oncology information systems to manage complex patient data, coordinate multidisciplinary treatment plans, and support clinical trials. The increasing patient influx to specialized cancer centers driven by rising cancer incidence and the demand for state-of-the-art treatment modalities underscores the importance of adopting integrated systems that enhance operational efficiency and clinical effectiveness. Additionally, hospitals and cancer centers invest heavily in sophisticated infrastructure, such as radiation therapy units and chemotherapy delivery systems, which rely on advanced oncology IT platforms to ensure accuracy and safety. The focus on improving patient outcomes through evidence-based protocols and personalized medicine further necessitates comprehensive data management and analytic capabilities offered by oncology information systems. Consequently, the centrality of hospitals and cancer centers in cancer care delivery promotes ongoing investment and innovation in this segment.

Regional Insights:

Dominating Region: North America

In North America, the dominance in the Oncology Information System (OIS) market is largely driven by a mature healthcare ecosystem supported by advanced technological infrastructure and substantial investments in cancer care. The presence of a highly developed healthcare IT landscape enables seamless integration of oncology information systems with electronic health records (EHR) and hospital information systems (HIS). Strong government backing through healthcare regulations like the Affordable Care Act encourages adoption of digital health solutions for improved cancer patient management. Furthermore, North America hosts a concentration of leading pharmaceutical and medical device companies such as Varian Medical Systems (a Siemens Healthineers company), Elekta, and Epic Systems, which actively contribute to innovation and tailored oncology IT solutions. The extensive clinical research activities and well-established reimbursement frameworks facilitate widespread deployment of sophisticated oncology information systems, reinforcing the region's leadership in the market.

Fastest-Growing Region: Asia Pacific

Meanwhile, the Asia Pacific region exhibits the fastest growth within the Oncology Information System market, driven by expanding healthcare infrastructure and rising cancer awareness across emerging economies. Countries like China, India, Japan, South Korea, and Australia are investing heavily in upgrading hospital IT infrastructures and implementing digital health policies to improve cancer diagnosis and treatment outcomes. Government incentives and strategic partnerships with global technology providers have accelerated the adoption of oncology information systems tailored to local patient demographics and clinical workflows. Additionally, increasing incidences of cancer and growing patient populations necessitate efficient data management, fueling demand for OIS solutions. Prominent companies such as Philips Healthcare, GE Healthcare, and IBM Watson Health have been expanding their footprint in this region through collaborations with local players and customized software platforms, supporting the dynamic growth momentum in Asia Pacific.

Oncology Information System Market Outlook for Key Countries

United States

The United States market continues to lead due to its advanced medical infrastructure and substantial investments in health IT. Major players including Varian Medical Systems and Epic Systems have established comprehensive oncology information systems that integrate treatment planning, patient management, and clinical decision support. The country's focus on precision medicine and value-based care models further drives the enhancement and adoption of sophisticated oncology IT solutions, enabling improved patient outcomes and streamlined clinical workflows.

Germany

Germany's oncology information system market benefits from its robust healthcare ecosystem and government policies promoting digitization in healthcare. Siemens Healthineers and Agfa HealthCare are key contributors, providing oncology software systems that support radiation oncology treatment and patient data management. The country's strong emphasis on clinical research and regulatory support for health IT adoption fosters an environment conducive to implementing integrated oncology solutions across major cancer centers and hospitals.

China

China is at the forefront of rapid market expansion due to escalating cancer prevalence and significant government investments in healthcare modernization and digital health initiatives. Companies like Philips Healthcare, GE Healthcare, and local firms such as Neusoft Medical Systems are actively enhancing oncology information system capabilities tailored to the local market. The emphasis on improving cancer screening programs and healthcare accessibility further propels OIS demand, supported by strategic collaborations and joint ventures between international and domestic players.

Japan

Japan maintains a technologically advanced market with noteworthy contributions from Toshiba Medical Systems (now Canon Medical Systems) and Hitachi. The country's well-developed healthcare infrastructure coupled with a growing elderly population drives the need for efficient oncology data management solutions. Government support for healthcare IT and integration of AI into oncology information systems underpin efforts to optimize treatment workflows and improve prognosis prediction and patient monitoring.

Australia

Australia's oncology information system market is characterized by increasing adoption within public and private healthcare institutions. The country benefits from government initiatives aimed at boosting digital health adoption and cancer care efficiency. Key companies such as Elekta and Cerner Corporation have developed oncology IT platforms that support treatment planning and registry management tailored for Australian clinical practices. Enhanced focus on multidisciplinary cancer care and data interoperability enhances market maturity and growth potential within the region.

Market Report Scope

Market Segmentation

System Type Insights (Revenue, USD, 2020 - 2032)

• Treatment Planning Systems
• Electronic Health Records (EHR) Systems
• Radiation Oncology Information Systems (ROIS)
• Chemotherapy Management Systems
• Others

Component Insights (Revenue, USD, 2020 - 2032)

• Software
• Services
• Hardware
• Others

End-user Insights (Revenue, USD, 2020 - 2032)

• Hospitals and Cancer Centers
• Research Institutes
• Ambulatory Clinics
• Others

Regional Insights (Revenue, USD, 2020 - 2032)

• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa

Key Players Insights

• Elekta AB
• Varian Medical Systems (Siemens Healthineers)
• Cerner Corporation
• Epic Systems Corporation
• GE Healthcare
• McKesson Corporation
• Groupe Anthelio
• RaySearch Laboratories AB
• Philips Healthcare
• IBM Watson Health
• Accuray Incorporated
• Siemens Healthineers
• Agfa-Gevaert Group
• Precision Radiation Medicine
• ViewRay Inc.
• AstraZeneca (Oncology IT Division)
• MEDITECH
• Mach7 Technologies
• Aria Oncology (Varian product)
• Mirada Medical